We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Saliva Test to Enable Early Detection of Diabetes and Obesity

By LabMedica International staff writers
Posted on 04 Aug 2025

Type 2 diabetes affects about 400 million people globally and is typically diagnosed through elevated blood glucose levels. More...

However, conditions like insulin resistance and hyperinsulinemia may begin developing 10 to 20 years before a diagnosis. Detecting hyperinsulinemia early is important because it is a known predictor of several chronic conditions, including Type 2 diabetes, hypertension, cardiovascular disease, stroke, cancer, and obesity. Current methods to detect insulin levels require invasive blood sampling and lab-based analysis, making early detection less accessible. Now, a new study reveals that a saliva-based test may offer a simple, non-invasive method to identify people at risk of developing metabolic disorders, even before symptoms appear or blood sugar levels begin to rise.

The study, by researchers at the UBC Okanagan’s School of Health and Exercise Sciences (Kelowna, BC, Canada), evaluated whether insulin levels in saliva could serve as a reliable indicator of metabolic health. The research included 94 healthy participants across a range of body sizes who, after a fasting period, consumed a standardized meal-replacement shake. Saliva samples were collected at 30, 60, and 90 minutes post-consumption, alongside finger-prick blood glucose tests. Prior studies at UBCO had already shown that saliva insulin levels closely track plasma insulin levels throughout the day, even after meals with differing carbohydrate contents. This new study aimed to build on that insight and develop a practical, needle-free test for early detection of hyperinsulinemia.

The findings, published in Applied Physiology, Nutrition, and Metabolism, indicate that saliva insulin levels were significantly higher in individuals with obesity, even when their blood glucose levels remained normal. The study also discovered that some lean individuals exhibited large saliva insulin spikes after the test meal, suggesting elevated risk despite healthy weight and glucose levels. Additionally, waist circumference showed a stronger correlation with elevated saliva insulin than age or overall body weight, indicating it may be a better predictor of early metabolic dysfunction. Researchers suggest that saliva testing could become a valuable tool to distinguish between metabolically healthy individuals and those at risk, and future work will focus on refining this method for broader clinical application.

"If hyperinsulinemia can be detected before blood glucose levels start to rise, people at risk for Type 2 diabetes could be identified early, allowing for lifestyle changes and other treatments to be introduced long before glucose levels rise," said Dr. Jonathan Little, lead investigator of the study.

Related Links:
UBCO School of Health and Exercise Sciences


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The screening algorithm incorporates two plasma biomarkers: amyloid-beta ratio and p-tau217, which together help indicate brain amyloid burden (Image Credit: Shutterstock)

Algorithm Uses Blood Biomarkers to Improve Alzheimer’s Trial Screening

Alzheimer’s disease is a progressive neurodegenerative disorder that causes memory loss and functional decline. Screening cognitively healthy adults for prevention trials is slow and costly because many... Read more

Microbiology

view channel
Image: The current BDBV outbreak in the DRC underscores response challenges for rare, severe infections (Image Credit: 123RF)

Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics

Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read more

Technology

view channel
Image: The 5811 R retains the performance and versatility of its predecessor while adding a new design, a refreshed user interface, and updated sustainable cooling technology. (Photo courtesy of Eppendorf)

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more

Industry

view channel
Image: The combined offering is designed to streamline workflows and support multicolor applications used in leukemia, lymphoma, and measurable residual disease assessment in specialized clinical settings

Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry

Sysmex Europe SE (Hamburg, Germany) and Cytek Biosciences (Fremont, CA, USA) are partnering across more than a dozen European countries to expand access to advanced clinical flow cytometry.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.